Canadian digital health dev Swift Medical said today it raised $11.6 million in Series A funding to help support its digital wound care management system designed to assess and monitor wounds.
The round was led by Data Collective and joined by Real Ventures Relay Ventures and the Business Development Bank of Canada in Montreal, the Toronto-based company said.
Swift Medical has developed a smartphone-ready system, called Swift Skin and Wound, that captures images and measurements of wounds including wound depth without having to touch the wound or use other tools, including rulers or acetate tracings. The system also allows patients and attending clinicians to track their wounds during healing, the company said.
“This growth funding enables us to expand our reach and bring Swift’s solution to every bedside in every hospital and care facility. There are more patients worldwide suffering from chronic wounds than from lung cancer, breast cancer, colon cancer and leukemia combined. By augmenting the abilities of clinicians and facility administrators to deliver the best possible wound care management, we’re helping them heal over 10,000 patients a month. And we’re just getting started,” co-founder & CEO Carlo Perez said in a prepared statement.
“Swift’s product execution is a wonderful example of Data Collective’s computational care philosophy of pushing compute intelligence closer to the patient, but in a way that is empathetic to the patient and the caregivers and systems that surround them. We invested because of Swift’s near science-fiction quality machine vision, Carlo’s leadership, and because Swift enables wound care quality that all of us should demand for a loved one,” Data Collective partner Scott Barclay said in a press release.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.